SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 4, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 4 insiders, $0.3M total
Actionable Insight • Neutral

The cluster is too small to drive a trading signal. Monitor for any upcoming earnings or pipeline catalysts that could explain the timing, but the dollar amounts suggest routine diversification. No action warranted.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$23.49
T+0 close · May 3, 2026 · via day close
Latest settled
+18.60%
T+60 · $27.86
Vs SPY
+16.75%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 4 $23.49entry
  2. T+1 · 7mo ago −0.30%α −1.09% · $23.42
  3. T+5 · 6mo ago −9.58%α −12.51% · $21.24
  4. T+20 · 6mo ago −8.60%α −14.24% · $21.47
  5. T+60 · 4mo ago +18.60%α +16.75% · $27.86
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four Arcutis insiders sold a total of $283K in open-market sales over a one-week window, including the CFO and three other executives. The cluster is modest in size (0.01% of market cap) and occurred near the stock's recent highs, suggesting routine portfolio diversification rather than a coordinated bearish signal. The cross-filing actuarial verdicts amplify the cluster's significance, but the absolute dollar value is too small to warrant a directional call.

Key Financial Metrics

Direction
selling
Total Value
$283.0K
Insiders
4

Key Facts

  • Four insiders sold a total of $283K in open-market sales from May 4-11, 2026
  • CFO Latha Vairavan sold $32K; Matsuda Masaru sold $172K (largest trade)
  • Total sales represent ~0.01% of ARQT's $2.6B market cap, well below the 0.1% materiality threshold
  • All sales were open-market (code S); no non-cash transactions in the cluster
  • Stock traded between $21.05 and $23.61 during the window, near recent highs

Financial Impact

$283K in insider sales, negligible relative to $2.6B market cap

insider ownership

Risk Factors

  • Insider sales could accelerate if the stock continues to rally
  • No material business catalyst identified, cluster may be purely liquidity-driven

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1778715778269

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026